Removab
Active substance: catumaxomab
catumaxomab
Centralised EU authorisationWithdrawn
Marketing holder: Neovii Biotech GmbH
Verified 2026-10-09 · EMA
- Source: EMA
- Countries with the substance registered: 1
Composition
Registration
- Registration number
- EMEA/H/C/000972
- Registration status
- Withdrawn
- ATC code
- L01XC09
Sources
- product · EMA · EMEA/H/C/000972 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000972 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000972 · Verified 2026-10-09